187 related articles for article (PubMed ID: 16495186)
1. [Expression of CD25+ lymphocytes in nasopharyngeal carcinoma and its association with EBV infection].
Liu W; Han HX
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):94-7. PubMed ID: 16495186
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Epstein-Barr virus genotypes and clinicohistopathological features of nasopharyngeal carcinoma between Guilin, China and Fukuoka, Japan.
Zhou Y; Nabeshima K; Koga K; Aoki M; Hayashi H; Hamasaki M; Iwasaki H
Oncol Rep; 2008 Jun; 19(6):1413-20. PubMed ID: 18497945
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylation of epithelial-cadherin gene promoter is associated with Epstein-Barr virus in nasopharyngeal carcinoma.
Niemhom S; Kitazawa S; Kitazawa R; Maeda S; Leopairat J
Cancer Detect Prev; 2008; 32(2):127-34. PubMed ID: 18632221
[TBL] [Abstract][Full Text] [Related]
5. Expression of Epstein-Barr virus-encoded RNAs as a marker for metastatic undifferentiated nasopharyngeal carcinoma.
Chao TY; Chow KC; Chang JY; Wang CC; Tsao TY; Harn HJ; Chi KH
Cancer; 1996 Jul; 78(1):24-9. PubMed ID: 8646721
[TBL] [Abstract][Full Text] [Related]
6. The association of squamous cell carcinomas of the nasopharynx with Epstein-Barr virus shows geographical variation reminiscent of Burkitt's lymphoma.
Nicholls JM; Agathanggelou A; Fung K; Zeng X; Niedobitek G
J Pathol; 1997 Oct; 183(2):164-8. PubMed ID: 9390028
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus DNA in nasopharyngeal carcinoma in Thai patients at Ramathibodi Hospital, Bangkok.
Niemhom S; Maeda S; Raksakait K; Petchclai B
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():325-8. PubMed ID: 8629135
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
9. Expression of cytokine and chemokine genes in Epstein-Barr virus-associated nasopharyngeal carcinoma: comparison with Hodgkin's disease.
Beck A; Päzolt D; Grabenbauer GG; Nicholls JM; Herbst H; Young LS; Niedobitek G
J Pathol; 2001 Jun; 194(2):145-51. PubMed ID: 11400141
[TBL] [Abstract][Full Text] [Related]
10. Expression of the interferon-inducible chemokine IP-10 (CXCL10), a chemokine with proposed anti-neoplastic functions, in Hodgkin lymphoma and nasopharyngeal carcinoma.
Teichmann M; Meyer B; Beck A; Niedobitek G
J Pathol; 2005 May; 206(1):68-75. PubMed ID: 15751051
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus DNA, intermediate filaments and epithelial membrane antigen in nasopharyngeal carcinoma.
Friedrich RE; Bartel-Friedrich S; Lobeck H; Niedobitek G; Arps H
Anticancer Res; 2000; 20(6D):4909-16. PubMed ID: 11326639
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of the expression of the Epstein-Barr virus (EBV) anti-apoptotic gene BHRF1 in nasopharyngeal carcinoma and EBV-related lymphoid diseases.
Nicholls J; Kremmer E; Meseda CA; Mackett M; Hahn P; Gulley ML; Brink A; Swinnen LJ; Greenspan J; De Souza Y; Grässer F; Sham J; Ng MH; Arrand JR
J Med Virol; 2001 Sep; 65(1):105-13. PubMed ID: 11505451
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma.
Shao JY; Zhang Y; Li YH; Gao HY; Feng HX; Wu QL; Cui NJ; Cheng G; Hu B; Hu LF; Ernberg I; Zeng YX
Anticancer Res; 2004; 24(6):4059-66. PubMed ID: 15736452
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus infection of sinonasal lymphoepithelial carcinoma in Guangzhou.
Zong Y; Liu K; Zhong B; Chen G; Wu W
Chin Med J (Engl); 2001 Feb; 114(2):132-6. PubMed ID: 11780191
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus LMP1 status in relation to apoptosis, p53 expression and leucocyte infiltration in nasopharyngeal carcinoma.
Shao JY; Ernberg I; Biberfeld P; Heiden T; Zeng YX; Hu LF
Anticancer Res; 2004; 24(4):2309-18. PubMed ID: 15330177
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical absence of CD21 membrane receptor in nasopharyngeal carcinoma cells infected by Epstein-Barr virus in Spanish patients.
Burgos JS; Vera-Sempere FJ
Laryngoscope; 2000 Dec; 110(12):2081-4. PubMed ID: 11129025
[TBL] [Abstract][Full Text] [Related]
17. The expression of p63 is associated with the differential stage in nasopharyngeal carcinoma and EBV infection.
Guo C; Pan ZG; Li DJ; Yun JP; Zheng MZ; Hu ZY; Cheng LZ; Zeng YX
J Transl Med; 2006 May; 4():23. PubMed ID: 16729897
[TBL] [Abstract][Full Text] [Related]
18. [Quantitative analysis of Epstein-Barr virus DNA in plasma and peripheral blood cells in patients with nasopharyngeal carcinoma].
Zhang Y; Gao HY; Feng HX; Deng L; Huang MY; Hu B; Cheng G; Wu QL; Cui NJ; Shao JY
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(12):982-6. PubMed ID: 15312530
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma.
Niedobitek G; Agathanggelou A; Nicholls JM
Semin Cancer Biol; 1996 Aug; 7(4):165-74. PubMed ID: 8946600
[TBL] [Abstract][Full Text] [Related]
20. [Quantitative and localized detection of Epstein-Barr virus infectious status in nasopharyngeal carcinoma tissue].
Jiang WH; Zhao SP; Yin ZH; Li F; Chen ZH; Xiao JY
Ai Zheng; 2005 Jul; 24(7):796-800. PubMed ID: 16004803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]